Syneos Health announced a strategic partnership with uMotif. The collaboration will help accelerate clinical trials and bring new therapies to patients faster through a more efficient, end-to-end digital platform that includes robust Electronic Clinical Outcome Assessment (eCOA) and Electronic Patient-reported Outcomes (ePRO) capabilities. In addition to uMotif providing eCOA and ePRO services for Syneos Health customers, the companies will develop and deploy an exclusive patient-centric platform to deliver seamless, integrated customer solutions - including patient identification, recruitment, eConsent, eDiary, patient engagement and retention, and payments.

Complemented by the Company's StudyKIK recruitment technology platform, Syneos Health will build a single application to help drive better engagement, compliance and retention with patients, and reduce site burden. The uMotif cloud-native and highly configurable platform is collaboratively designed with patients, healthcare professionals, monitors, data managers and sponsors. The modern platform can be quickly adapted to meet protocol specific requirements, providing optimal flexibility for sponsors, sites and patients.

This partnership demonstrates Syneos Health's continued investment in technology and data solutions that accelerate clinical development, integrating the voice of the site and patient to optimize performance for biopharma customers.